Triflubazam

Triflubazam is a benzodiazepine derivative with anxiolytic properties. It is primarily used in the treatment of anxiety disorders and has a chemical structure similar to other benzodiazepines.
Pharmacology[edit]
Triflubazam works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, which results in its anxiolytic effects. This mechanism is common among benzodiazepines, which are known for their sedative, muscle relaxant, and anticonvulsant properties.
Medical Uses[edit]
Triflubazam is prescribed for the management of anxiety disorders. It may also be used in the treatment of other conditions as determined by a healthcare provider. The drug is known for its efficacy in reducing symptoms of anxiety and has a profile similar to other benzodiazepines.
Side Effects[edit]
Common side effects of triflubazam include drowsiness, dizziness, and fatigue. As with other benzodiazepines, there is a risk of dependence and withdrawal symptoms if the medication is used for extended periods or at high doses. Other potential side effects include cognitive impairment, coordination problems, and gastrointestinal disturbances.
Contraindications[edit]
Triflubazam should not be used in individuals with a known hypersensitivity to benzodiazepines. It is also contraindicated in patients with severe respiratory insufficiency, sleep apnea, and myasthenia gravis. Caution is advised when prescribing triflubazam to individuals with a history of substance abuse or depression.
Interactions[edit]
Triflubazam can interact with other central nervous system depressants, including alcohol, opioids, and other benzodiazepines, which can enhance its sedative effects. It may also interact with medications that affect the cytochrome P450 enzyme system, potentially altering its metabolism and efficacy.
Legal Status[edit]
The legal status of triflubazam varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and dependence.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian